Best Agrolife (539660) Q1 24/25 earnings summary

Executive summary

• Q1 FY25 revenue declined to INR 519 crore from INR 612 crore in Q1 FY24, mainly due to a strategic shift toward branded business, lower institutional sales, and delayed monsoon impacting sales timing.

• Branded sales now contribute 63% of revenue, up from 55% last year, reflecting a focus on higher-margin patented products and innovation.

• Several new patented products were launched, including Orisulam, NemaGen, Warden Extra, and Defender, with a new patent secured for a Stable Synergistic Pesticidal Composition.

• Early monsoon and intensified La Niña conditions improved agricultural sentiment, boosting Kharif sowing by 10% year-over-year and aiding inventory liquidation.

• Board approved unaudited standalone and consolidated financial results for Q1 FY25, with statutory auditor review completed.

Financial highlights

• Q1 FY25 EBITDA (excluding other income) was INR 55 crore, down from INR 130 crore in Q1 FY24, with margin falling to 11% from 21% due to higher expenses and liquidation of expensive inventory.

• Q1 FY25 PAT was INR 21 crore, compared to INR 91 crore in Q1 FY24, with PAT margin at 4% versus 15% a year ago.

• Consolidated revenue from operations for Q1 FY25 was ₹5,192.60 million, down from ₹6,122.32 million in Q1 FY24; consolidated net profit was ₹212.75 million, compared to ₹905.04 million in Q1 FY24.

• Branded business volumes increased by 21%, but price erosion of 19% led to flat revenue growth in this segment.

• Trading revenue accounted for INR 100 crore (20% of total), down from 30% previously, with a plan to reduce further.

Outlook and guidance

• Full-year FY25 revenue growth expected at 15%-20%, with EBITDA margin guidance of 15%-17%.

• Q2 and subsequent quarters are expected to show improved margins and higher contributions from new patented products as inventory is liquidated and monsoon conditions remain favorable.

• Focus on launching new, higher-margin products, ramping up branded business, and improving cash flow and working capital cycle.

• Management has not identified the need for any adjustments in the financial results due to ongoing tax investigations.